Trevena Inc. - TRVN Net Assets per Single Share
Trevena, Inc. (TRVN) generates revenue from the sale of non-opioid analgesics in hospitals, creating a moderate cash flow. On GURU.Markets, this linear chart of the current BVPS demonstrates capital dynamics, where the current level equals -22.14. Technological leadership in the CNS space is driven by the innovative drug Olinvyk, while patent protection and strict FDA regulations create significant barriers to entry for new players.
trevena.com - analytical breakdowns and key metrics (TRVN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Trevena, Inc, TRVN
When screening assets, an investor evaluates the intrinsic value of a business through the difference between total assets and liabilities divided by the number of shares. For Trevena, Inc. (TRVN), which minimizes capital expenditures by outsourcing production and research, this metric reflects the actual volume of equity, allowing for the calibration of overpayment risks by analyzing the dynamics of the book value per common share.
Competitor analysis
BIIB - Accounting Value per Share|NBIX: Net Assets per Single Share|Net Assets per Single Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Net Asset Value per Share Trevi Corp|Praxis Precision Medicines (PRAX) - Accounting Value per Share|Book Price of a Share AVXL|CeriBell (CBLL) - Net Assets per Single Share|Accounting Value of a Share Prothena Corporation (PRTA)|ALEC: Book Value per Share|ANNX - Net Asset Value per Share|OMER - Accounting Value per Share|NGNE - Net Assets per Single Share|Book Value per Share ACIU|VYGR (Voyager Therapeutics Inc) - Net Asset Value per Share|Net Assets per Single Share Neumora Therapeutics Inc (NMRA)|Equity per Share Scilex Holding Company, Inc.|Book Value per Share TVGN|Book Value per Share alphacognition.com ACOG|Accounting Value per Share Cognition Therapeutics|Accounting Value of a Share Inhibikase Therapeutics Inc IKT|Book Value per Share SAVA (Cassava)|ASRT: Net Assets per Share|Net Assets per Single Share coyatherapeutics.com|Vistagen (VTGN) - Equity per Share|Book Value per Share OVID|Accounting Value per Share Acumen Pharmaceuticals Inc. (ABOS)|CRVO (CervoMed Inc) - Accounting Value per Share|Net Assets per Share alteritytherapeutics.com ATHE|Accounting Value per Share Clene (CLNN)|PepGen Inc - Book Price of a Share|Net Assets per Single Share Jupiter Neurosciences Inc (JUNS)|Relmada Therapeutics Inc (RLMD) - Accounting Value of a Share|Annovis Bio Corp (ANVS) - Accounting Value per Share|GRCE (Grace Therapeutics) - Net Assets per Single Share|Net Assets per Single Share Firefly Neuroscience, Inc (AIFF)|Equity per Share KLTO|Net Assets per Single Share NeuroSense Therapeutics NRSN|Equity per Share Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA: Book Value per Share|NRXS - Net Asset Value per Share|Helius Medical Technologies Inc. - Accounting Value per Share|PASG: Book Value per Share|Net Assets per Single Share bionomics.com.au NEUP|NERV (Minerva Neurosciences Inc) - Accounting Value of a Share|Net Assets per Single Share ATHA (Athira)|Net Asset Value per Share Addex (ADXN)|Accounting Value per Share Alzamend Neuro, Inc.|Book Price of a Share CYCN (cyclerion.com)|Net Assets per Single Share Protagenic Therapeutics, Inc.|Accounting Value of a Share Pasithea Therapeutics Corp KTTA|CRGT (Cortigent Medical) - Book Value per Share|Avenue Therapeutics Inc (ATXI) - Net Asset Value per Share|Brainstorm Cell (BCLI) - Accounting Value per Share|caratherapeutics.com (CARA) - Net Assets per Single Share|Book Value per Share CHRO (Chromocell Therapeutics Corp.)|Net Asset Value per Share ELYM|Net Assets per Single Share Intra-Cellular Therapies ITCI|Equity per Share Longboard (LBPH)|Book Value per Share MRNS (Marinus Pharmaceuticals)|NKGN - Book Value per Share|Accounting Value per Share NeuroBo Pharmaceuticals, Inc. (NRBO)|SAGE - Accounting Value of a Share|Neurotrope - Book Value per Share|VIGL (Vigil Neuroscience, Inc.) - Net Assets per Share|Net Assets per Single Share Anew Medical (WENA)|Equity per Share cerevel.com